CHF 45.40
Market Cap
2.5 Mrd. CHF
P/E Ratio
4.3
52-Week Range
CHF 24.35 – CHF 49.65
+CHF 10.20 (+28.98%)
BB Biotech is trading at CHF 45.40, up CHF 10.20 (+28.98%) over the selected period.
What you actually receive as a Swiss investor, after the 35% withholding tax (Verrechnungssteuer).
Gross Dividend Yield
4.88%
Net Dividend Yield
3.17%
Annual Dividend / Share
CHF 2.25
Payout Ratio
17.08%
Switzerland applies a 35% withholding tax (Verrechnungssteuer) on dividends. As a Swiss tax resident, you can reclaim this amount in full through your annual tax return (DA-1 form). The net yield shown reflects what you receive before reclaiming.
Revenue Growth
616.7%
Profit Margins
93.9%
Earnings Growth
692.0%
Return on Equity
22.8%
Explore other top Swiss companies
Market data is sourced from public financial data providers. Prices may be delayed. Data is for informational purposes only and does not constitute investment advice.